MOMO'S BREAKOUT BOARD

[papadedavid]

PMCB - MJ company

Not a small neither a new one in this field...this is an extract from an 2013 article in forbes:

JT: I don’t understand the mix of business lines. I think it would be beneficial to focus on cell encapsulation and put the majority of the resources into that. While medicinal marijuana is expanding and likely to be widely legal soon-ish, it seems like a distraction compared to Cell-in-a-Box. Some doctors and scientists I speak with have expressed similar sentiments.

NVLX Management[/entity][/entity]: We do not consider the cell encapsulation and medical marijuana arms of the company to be mutually exclusive. In fact, we consider them to be complementary as we will explain.

NVLX is divesting itself of the nutraceuticals that have been a major part of its portfolio for years and is becoming a purely biotech company that has two major areas to consider, namely cell encapsulation and medical marijuana (JT: Many critics cite the fact that despite such a long and less than illustrious past, the company necessarily has little/no future. The above statement alone should help allay many of those concerns). The initial thrust of the company is to get its cell encapsulation-based pancreatic cancer treatment into late-phase clinical trials. However, one of the goals in the medical marijuana arena is to develop a “treatment” for advanced pancreatic cancer based initially on constituents of cannabis. There are many articles in the scientific literature that speak to the ability of cannabis constituents to “kill” pancreatic cancer cells in vitro and in animals.

In addition, these constituents are well recognized as being effective pain killers and may also be able to ameliorate symptoms of the cachexia (wasting syndrome) that accompanies advanced cancers. So, one must ask the question “why not combine the cell encapsulation-based pancreatic cancer treatment with a cannabis-based treatment?” In our considered opinion, at the very least, the two therapies in combination would allow for effective treatment of the cancer while significantly improving the “quality of life” of the patients undergoing therapy. However, we firmly believe that the overall treatment of the cancer will be improved using the combination of treatments. After all, isn’t this what combination chemotherapy of cancer is all about? (JT: I’m on traditional pain killers while writing this – for back pain, not cancer, just to clear that up – and know too many people with cancer, diabetes, etc who would be ecstatic with any improvements such quality of life enhancing technologies could deliver).

http://www.forbes.com/sites/jordanterry/2013/04/05/a-skeptics-take-on-nuvilex-after-speaking-with-management-patience-should-be-rewarded/#a3999ce32437

NOW SEE WHAT IT DID IN EARLY 2014!!!...ABSOLUTELY NO BRAINER AT THESE LEVELS WITH ALL THE MJ HYPE GOING ON.